In La Wantzenau, France, a groundbreaking pilot program is proving that golf—yes, golf—can be a transformative rehabilitation tool for patients with chronic respiratory diseases like COPD and asthma. This week, a multidisciplinary team of pulmonologists, sports physiologists, and occupational therapists demonstrated how controlled physical activity, tailored to lung mechanics, can improve forced expiratory volume (FEV1) by up to 12% over 12 weeks in select patients. The initiative, funded by the French National Institute of Health and Medical Research (INSERM), bridges a critical gap in pulmonary rehabilitation: the psychological and social barriers that often prevent patients from engaging in structured exercise. With chronic respiratory diseases affecting over 65 million people globally, this model offers a scalable, low-cost intervention—one that could reshape public health strategies in regions where access to pulmonary rehab is limited.
The program’s success hinges on a counterintuitive insight: golf’s rhythmic, low-impact swings and strategic pacing align with the ventilatory thresholds of patients with obstructive lung diseases. Unlike high-intensity interval training (HIIT), which is often contraindicated for severe COPD patients due to its risk of hypercapnic respiratory failure, golf’s intermittent bursts of effort (e.g., driving the ball) are interspersed with recovery phases (walking between holes), mirroring the Borg Rating of Perceived Exertion (RPE) scale used in pulmonary rehab. Preliminary data from the La Wantzenau cohort—published in this week’s European Respiratory Journal—shows that patients who completed the 12-week program reported a 30% reduction in dyspnea (shortness of breath) during daily activities, a clinically meaningful improvement.
In Plain English: The Clinical Takeaway
- Golf isn’t just for retirees—it’s a structured, doctor-approved way to rebuild lung strength without overtaxing your body. The key? Playing at a pace that keeps your heart rate in the “talk test” zone (you can speak in full sentences but not sing).
- Your lungs and your mind benefit equally. COPD and asthma don’t just limit breathing—they isolate patients. Golf’s social nature (partner play, club camaraderie) combats depression, a major comorbidity in chronic lung disease.
- This isn’t a cure, but it’s a game-changer. While it won’t reverse emphysema or asthma, the La Wantzenau program shows that sustained, moderate exercise can improve lung function by up to 12%—equivalent to the effects of some inhaled corticosteroids in early-stage COPD.
Why This Matters Beyond the Fairways: The Science of Breathing and Movement
The La Wantzenau initiative builds on decades of research into exercise-induced bronchoconstriction (EIB), a paradoxical reaction where physical exertion triggers airway narrowing in some asthma patients. Historically, this has led clinicians to advise against high-intensity sports. However, the French study’s breakthrough lies in its personalized pacing protocol:
- Phase 1 (Weeks 1–4): Patients practiced “chip shots” (short, controlled swings) on a driving range, focusing on diaphragmatic breathing. This phase targeted accessory muscle recruitment (e.g., neck/shoulder muscles compensating for weak diaphragm function in COPD).
- Phase 2 (Weeks 5–8): Introduced the “walking rule”: players could drive the ball only if they could walk the distance to the next hole without stopping. This ensured oxygen consumption (VO2) remained below anaerobic thresholds.
- Phase 3 (Weeks 9–12): Full 18-hole rounds with a pulmonologist on-site to monitor transcutaneous capnography (a non-invasive way to track CO2 levels in blood).
Critically, the program avoided the Valsalva maneuver (forceful exhalation against a closed airway), a common pitfall in golf that can exacerbate COPD exacerbations. Instead, players were trained to exhale gradually during the follow-through, a technique borrowed from ERS pulmonary rehab guidelines.
Global Implications: How This Changes Pulmonary Rehab Everywhere
The La Wantzenau model isn’t just a French curiosity—it’s a blueprint for adapting sports to chronic disease. Here’s how it could reshape healthcare systems:
1. Epidemiological Context: COPD’s Silent Crisis
Chronic obstructive pulmonary disease (COPD) is the third-leading cause of death worldwide, with 16 million Americans and over 3 million Europeans diagnosed. Yet only 20% of eligible patients participate in pulmonary rehabilitation programs due to barriers like cost, mobility issues, and stigma. Golf’s accessibility—over 36,000 courses globally—could bridge this gap.

2. Regulatory and Systemic Adoption
While the La Wantzenau study is still in its Phase II pilot stage (N=87 patients), its findings align with recent regulatory shifts:
- Europe (EMA/NHS): The UK’s NHS COPD management guidelines already recommend “low-to-moderate intensity exercise” but lack sport-specific protocols. The La Wantzenau data could prompt NHS to partner with golf clubs for “prescription golf” programs.
- USA (CDC/FDA): The CDC’s 2023 COPD Toolkit highlights the need for “novel delivery models” for pulmonary rehab. Golf’s structured environment could qualify as a “covered benefit” under Medicare’s Chronic Care Management (CCM) code (CPT 99490), expanding reimbursement options.
- Low-Resource Settings: In countries like India (where COPD mortality rates are 3x higher than the global average), golf courses are rare—but public parks with driving ranges could replicate the model at minimal cost.
Funding and Potential Conflicts of Interest
The La Wantzenau study was funded by a €1.2 million grant from INSERM, with additional support from the French Golf Federation. While the federation provided pro bono coaching and course access, the study’s principal investigator, Dr. Sophie Lefèvre (PhD, Pulmonology, Université de Strasbourg), confirmed that:
“The golf industry had no input on patient selection, exercise protocols, or outcome measures. Our primary goal was clinical efficacy, not promotion of the sport. That said, the model’s scalability is now being explored by the WHO’s Physical Activity Unit for integration into their Global Action Plan on Physical Activity.”
Critics may question whether golf’s elitist reputation could limit participation. However, the study included patients from urban, rural, and semi-urban areas, with 40% on government-subsidized healthcare. “We prioritized accessibility,” said Lefèvre. “Many patients had never played golf before—they were there for the rehabilitation, not the prestige.”
The Data: Who Benefits Most?
Below is a summary of the La Wantzenau cohort’s demographics and outcomes, compared to traditional pulmonary rehab programs:
| Metric | La Wantzenau Golf Program (N=87) | Standard Pulmonary Rehab (N=120, per ERS 2019 Meta-Analysis) |
|---|---|---|
| Average FEV1 Improvement | 12% (from 48% predicted to 54%) | 9–11% (from 45% to 50%) |
| 6-Minute Walk Test (6MWT) Gain | 52 meters (from 380m to 432m) | 45 meters (from 370m to 415m) |
| Patient Adherence Rate | 89% (completed ≥80% sessions) | 62% (dropout rate 38%) |
| Hospitalization Rate (12 Months Post-Program) | 18% (for COPD exacerbations) | 28% (control group) |
| Cost per Patient | €850 (subsidized by INSERM) | €1,200–€1,800 (traditional rehab centers) |
Note: The golf program’s higher adherence may stem from its social and competitive elements. A 2024 JAMA Network Open study found that group-based exercise programs reduce dropout rates by 40% compared to solo training.
Contraindications & When to Consult a Doctor
While golf-based pulmonary rehab shows promise, it’s not suitable for everyone. Patients with the following conditions should consult their pulmonologist before participating:
- Severe hypoxemia (PaO2 < 55 mmHg on room air): The physical demands of walking 18 holes could worsen ventilation-perfusion mismatch, increasing the risk of acute respiratory failure. Supplemental oxygen may be required.
- Recent COPD exacerbation (<3 months): The study excluded patients within 90 days of hospitalization for COPD. “Your lungs need time to recover from inflammation,” warns Dr. Lefèvre. “Pushing too soon can trigger a cycle of decline.”
- Uncontrolled cardiac conditions: Golf involves standing for long periods and sudden movements (e.g., swinging). Patients with cor pulmonale (right-heart failure due to lung disease) or uncontrolled hypertension should avoid the program until cleared by a cardiologist.
- Severe osteoporosis or joint replacements: The repetitive motion of golf swings can stress weight-bearing joints. Physical therapy assessment is recommended.
When to Seek Emergency Care: Stop the activity and call emergency services if you experience:
- Blue lips or fingertips (cyanosis)
- Chest pain radiating to the shoulder/arm
- Inability to speak more than 2–3 words without pausing for breath
- Confusion or dizziness (signs of hypercapnia)
The Future: Can Golf Be Prescribed Worldwide?
The La Wantzenau study is just the beginning. Researchers are now exploring:
- Tele-golf programs: Virtual reality golf simulators could bring the benefits to patients in remote areas, with real-time monitoring via wearables (e.g., WHO-endorsed digital health tools).
- Hybrid models: Combining golf with traditional pulmonary rehab (e.g., 3x/week golf + 1x/week treadmill training) to maximize FEV1 gains.
- Pediatric applications: Early data suggests golf’s structured pacing could help children with cystic fibrosis (CF) maintain lung function during adolescence, a critical window for disease progression.
Dr. Lefèvre cautions against overhyping the results: “This isn’t a silver bullet. But for patients who’ve been told to ‘slow down,’ golf offers a way to reclaim activity without fear. The next step is proving it works in diverse populations—and that’s what we’re doing now.”
The WHO’s 2023 Global Report on Physical Activity highlights that only 28% of adults worldwide meet the minimum guidelines for physical activity. Chronic respiratory diseases disproportionately affect older adults and low-income groups—both populations least likely to engage in structured exercise. Golf’s unique blend of social support, controlled intensity, and accessibility could be the key to closing this gap.
References
- Lefèvre, S. Et al. (2026). “Golf as Pulmonary Rehabilitation: A Phase II Pilot Study in COPD Patients.” European Respiratory Journal.
- ERS Guidelines on Physical Activity for COPD (2022).
- Liao, Y. Et al. (2024). “Group-Based Exercise Adherence in Chronic Diseases: A Systematic Review.” JAMA Network Open.
- WHO Fact Sheet on Chronic Respiratory Diseases (2023).
- CDC COPD Data & Statistics (2025).
Disclaimer: This article is for informational purposes only and not a substitute for professional medical advice. Always consult your healthcare provider before starting any new exercise program, especially if you have a chronic respiratory condition.